Search

Author/Creator Strassmann, Valerie

1. Florbetapir (18F) for brain amyloid positron emission tomography: Highlights on the European marketing approval. (13th January 2014)

Authors:
Cortes‐Blanco, Anabel; Prieto‐Yerro, Concha; Martinez‐Lazaro, Raul; Zamora, Javier; Jiménez‐Huete, Adolfo; Haberkamp, Marion; Pohly, Johannes; Enzmann, Harald; Zinserling, Jörg; Strassmann, Valerie; Broich, Karl
Journal:
Alzheimer's & dementia
Issue:
Volume 10(2014)Supplement 5
Page Start:
S395
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Marketing Authorization Applications Made to the European Medicines Agency in 2018–2019: What was the Contribution of Real‐World Evidence?. Issue 1 (13th November 2021)

Authors:
Flynn, Robert; Plueschke, Kelly; Quinten, Chantal; Strassmann, Valerie; Duijnhoven, Ruben G.; Gordillo‐Marañon, Maria; Rueckbeil, Marcia; Cohet, Catherine; Kurz, Xavier
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 111:Issue 1(2022)
Page Start:
90
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The ENCePP Code of Conduct: A best practise for scientific independence and transparency in noninterventional postauthorisation studies. Issue 4 (5th March 2019)

Authors:
Gini, Rosa; Fournie, Xavier; Dolk, Helen; Kurz, Xavier; Verpillat, Patrice; Simondon, François; Strassmann, Valerie; Apostolidis, Kathi; Goedecke, Thomas
Journal:
Pharmacoepidemiology and drug safety
Issue:
Volume 28:Issue 4(2019)
Page Start:
422
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗